Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03700294 |
| Title | Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | ADC Therapeutics S.A. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarah Cannon Research Institute at HealthONE | Denver | Colorado | 80218 | United States | Details | |
| Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
| The Sarah Cannon Research Institute (Tennessee Oncology) | Nashville | Tennessee | 37203 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78240 | United States | Details |